Lyon AR, Dent S, Stanway S, Earl H, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a Position Statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Soci Eur J Heart Fail 2020 May 28. doi: 10.1002/ejhf.1920.
PMID: 32463967